Brian Chamberlain, PhD (he/him/his)

TandemAI, New York, United States

Brian Chamberlain Ph.D. is Senior Director, US Head of Medicinal Chemistry & Design at TandemAI where he leads a team of application scientists and drives medicinal chemistry strategy and integration with the computational platform. Previously, Dr. Chamberlain was Director of Medicinal Chemistry at Third Harmonic Bio and Senior Group Leader at the Broad Institute’s Center for the Development of Therapeutics. Brian was the first chemist to join Silicon Therapeutics (acquired by Roivant) where he was co-inventor of a STING agonist clinical candidate that was developed using physics-based computational tools. Dr. Chamberlain is an organic chemist by training holding a PhD in chemistry from USC with Prof. Charles E. McKenna and having completed post-doctoral training at UCLA in the laboratory of Prof. Michael E. Jung.

Disclosure information not submitted.

Presentation(s):

• Rapid optimization of small molecules using a fusion of physics-based simulations, AI and parallel chemistry

  Wednesday, February 7, 2024
  1:30 PM – 2:00 PM EST